Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients
NCT00478582 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2011-01-13
Summary
The clinical evaluation of anemia is usually done by examination of the palpebral conjontivae coloration. This appreciation remains crude and largely observer dependent, as no reference scale was successfully proposed,. A Hb visual scale allowing the assessment of the degree of clinical anemia has been developed. Its use has been validated so far in small patient groups in the following settings: blood donation, cardiac surgery, oncology and consultation of general practitioners.
The objective of the present investigation is to validate the use of a Hb visual scale for the clinical evaluation of anemia in patients with kidney disease patients
Conditions
Interventions
- PROCEDURE
-
Estimation of Hb concentrations with the HemoHue card
Sponsors & Collaborators
-
Insel Gruppe AG, University Hospital Bern
lead OTHER
Principal Investigators
-
Dominik Uehlinger, Prof
-
Dominik Uelinger, Prof
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-05-31
- Primary Completion
- 2007-12-31
- Completion
- 2007-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia
NCT00236977 ·Status: COMPLETED ·Phase: PHASE3
-
A Non-interventional, Epidemiological, Registry-based Evaluation of Anaemia in Swedish Patients With Chronic Kidney Disease
NCT03643601 ·Status: COMPLETED
-
Pilot Feasibility Study of a Novel Non-invasive Device for Diagnosis of Anemia
NCT06159348 ·Status: COMPLETED
-
Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis
NCT00236964 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Study of Correction of Anaemia With Darbepoetin Alfa at QM Dosing Interval in Patients With CKD Not on Dialysis
NCT02185911 ·Status: COMPLETED
-
Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD
NCT03388385 ·Status: UNKNOWN ·Phase: PHASE4
-
Renal Prognosis in Chronic Kidney Disease Patients With Hyporesponsive Anemia to Erythropoiesis Stimulating Agents
NCT02136563 ·Status: COMPLETED
-
4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis
NCT01587898 ·Status: COMPLETED ·Phase: PHASE2
-
Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility
NCT03128853 ·Status: COMPLETED ·Phase: NA
-
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
NCT02968368 ·Status: COMPLETED ·Phase: PHASE3
-
A Retrospective Observational Study of Hemoglobin Levels in Patients With Renal Anemia Treated With Mircera (Methoxy Polyethylene Glycol-Epoetin Beta)
NCT01379963 ·Status: COMPLETED
-
Efficacy and Safety of HSK39297 in Anti-C5 Treated PNH Patients With Anemia
NCT07052838 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Dose Response Relationship, Safety and Efficacy of GSK1278863 in Hemodialysis-dependent Subjects With Chronic Kidney Disease Associated Anemia
NCT01977482 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT06238544 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
NCT02930850 ·Status: COMPLETED ·Phase: NA
-
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
NCT00255424 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing Reticulocyte Hemoglobin and Transferrin Saturation to Guide Iron Treatment in People on Dialysis
NCT06906835 ·Status: RECRUITING ·Phase: NA
-
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
NCT00255437 ·Status: COMPLETED ·Phase: PHASE3
-
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
NCT03409107 ·Status: COMPLETED ·Phase: PHASE3
-
Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure
NCT00318812 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease
NCT00317239 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Renal Anemia
NCT01051323 ·Status: COMPLETED
-
Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)
NCT00869856 ·Status: WITHDRAWN ·Phase: PHASE3
-
Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)
NCT02876835 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase Ib, Multicenter, Open-Label Study of Multiple-Dose EA5 in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH)
NCT07256301 ·Status: RECRUITING ·Phase: PHASE1